The fund sold all its Mylan shares after it emerged that one of its products is in stock at a U.S. prison where death sentences are carried out.» Read More
Myndlift is a tech start-up combining mobile gaming with neurofeedback monitoring as an alternative to the surge in ADHD drug prescriptions.
Seventy percent of women who sought fertility treatments went into debt, according to a new study.
Cheaper biotech drugs are headed to the U.S., but analyst Mike Weinstein thinks J&J can manage through some of the challenges.
Deductibles have become a bigger factor in cases of people having insurance but being financially strained.
Drugstore operator CVS Health said it will acquire pharmacy service provider Omnicare for an enterprise value of about $12.7 billion.
Researchers at UC Irvine restored a key feature of young brains, the flexibility that allows for learning and creativity.
"You're going to have some wins and some that don't turn out," J&J chief Alex Gorsky tells CNBC. "But overall we're very confident."
Fewer than 250,000 people signed up for a special tax season enrollment period for Obamacare exchanges despite rising fines.
Four of the world's top disruptors agree that the healthcare industry needs a checkup. Here are the first things they would change.
Several new studies reveal that people's knowledge of health insurance and its costs remains low, which can lead to higher costs.
Obamacare has failed to deter emergency room visits because many patients still have no other choice, says Universal Health Services' Alan Miller.
People taking one vitamin pill twice a day have cut their risks for skin cancer by almost a quarter, NBC News reports.
A new study suggests Viagra can fight malaria, which still infects millions and kills half a million people every year.
As the list of drug-resistant bacteria grows, more research into new antibiotics is needed, according to ex-Goldman Sachs economist Jim O’Neill, who was also made U.K. Commercial Secretary on Thursday.
Here's a surprisingly easy and low-tech way to predict who's most likely to have a heart attack or stroke: measure their grip.
California's Obamacare exchange has lowered enrollment expectations, and Hawaii's exchange could shut down.
A controversial recommendation calls for women in their 40s with average risk of breast cancer to go without annual mammograms.
Pedialyte is going after a new market, and they don't have a bedtime...
Ahead of the world's biggest cancer research conference, the American Society of Clinical Oncology meeting, here are the companies to watch.
Options expert Stacey Gilbert explains why Celgene is trading at a discount to its peers.
Get the best of CNBC in your inbox